Skip to content
Open access

Apigenin promotes neuronal norepinephrine release via GPR30/PLCβ1-Ca2+-Syt1 signaling to enhance astrocytic lactate and exert neuroprotection in D-galactose-induced cognitive impairment

Oct 2026 · Frontiers in Pharmacology · 0 citations · 48 references

TL;DR

This study clarifies the PLCβ1-Ca 2+ -Syt1-dependent mechanism of Api in aging-related cognitive impairment, but also highlights NE and lactate elevation as a promising therapeutic approach.

Abstract

AD, a prevalent neurodegenerative disorder clinically defined by progressive cognitive impairment, is pathologically featured by early dysfunction of the locus coeruleus, depletion of noradrenergic (NE) neurons, and dysregulated astrocytic glycogen metabolism, which collectively compromise patients’ daily functioning. Although Api, a common phytoestrogen, has shown therapeutic efficacy in diverse diseases, its role and mechanism in AD remain unexplored. To address this gap, we evaluated the protective effects of Api against D-gal-induced cognitive deficits through behavioral and histomorphological assessments. Untargeted metabolomics was performed to profile metabolic alterations in the locus coeruleus (LC), complemented by targeted metabolomics focusing on specific pathways. Putative targets were predicted by molecular docking and verified via cellular thermal shift assay (CETSA), while molecular biology approaches were adopted to elucidate the underlying signaling cascades. Api significantly ameliorated D-gal-induced cognitive impairment and increased hippocampal NE and lactate levels with enhanced neuronal activity. Metabolomics indicated that Api regulates energy metabolism pathways including TCA cycle, amino acid metabolism, glycolysis/gluconeogenesis, and glutathione metabolism. Specifically, Api elevated NE and lactate in the LC. GPR30 was identified and validated as the key target via molecular docking and CETSA, showing strong binding affinity. Mechanistically, Api activates GPR30 on noradrenergic neurons to regulate PLCβ1-Ca 2+ -Syt1 signaling, promoting NE release, which in turn drives astrocytic glycogenolysis and lactate production, thereby relieving neuronal energy deficits. Collectively, this study not only clarifies the PLCβ1-Ca 2+ -Syt1-dependent mechanism of Api in aging-related cognitive impairment, but also highlights NE and lactate elevation as a promising therapeutic approach.

Read PDF

Similar papers

Oct 2026

Dihydrocaffeic acid alleviates APOE4-associated astrocyte dysfunction and cognitive impairment via LRP1/p38 MAPK signaling.

ETHNOPHARMACOLOGICAL RELEVANCE Dihydrocaffeic acid (DHCA) is a phenolic acid produced through the microbial metabolism of plant-derived caffeoylquinic acids. DHCA has been detected in human plasma following oral administration of a standardized aqueous extract of Centella asiatica (L.) Urb., a medicinal plant tradition...

Jia Shang, Yi-Wei Wang, Wei Wang et al. · 0 citations
Open access Oct 2026

PPAR-γ/SGK1/GSK3β/Nrf2 signaling pathway contributes to the neuroprotective effects of lycopene in depressed mice.

INTRODUCTION Major depressive disorder (MDD) is a neuropsychiatric disorder associated with abnormal neuronal activity in specific brain regions. Recent evidence suggests that oxidative stress- and neuroinflammation-driven impairments in synaptic structure and neuronal function may contribute to depression, yet the pre...

Yong-Si Zhao, Meng-Ni Chang, Cheng-Xin Hu et al. · 0 citations
Oct 2026

Isovitexin Attenuates Aβ-Induced Neurotoxicity by Activating SKN-1/Nrf2 Signaling and Suppressing Ferroptosis in Caenorhabditis elegans Models of Alzheimer's Disease.

Results showed that isovitexin significantly extended lifespan, reduced Aβ accumulation, and improved neuromuscular function, demonstrating marked neuroprotective effects, and support further investigation of isovitexin as a candidate for mitigating Aβ-induced neurodegeneration.

Meng-Jiao Hao, Dong-Ni Wu, Ling-Li Sun et al. · 0 citations
Open access Oct 2026

Cannabidiol Alleviates Aβ1–42-Induced Cognitive Deficits and Neuronal Injury Associated with Modulation of the AEA–FAAH–CB1R Axis and BDNF/TrkB Signaling

Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, synaptic dysfunction, and neuronal injury. Cannabidiol (CBD), a non-psychoactive constituent of Cannabis sativa L., has neuroprotective potential, but its underlying mechanisms remain unclear. Purpose: T...

Yan-Xia Kong, Juan Peng, Jian Sun et al. · 0 citations
Open access Oct 2026

Activation of CaMKIIα regulates hippocampal mitochondrial metabolism and attenuates neuroinflammation: A novel therapeutic target for obesity-associated neurocognitive disorders.

ABSTRACT Obesity is strongly associated with cognitive impairment, especially in memory. However, the underlying molecular mechanisms remain unclear. Ca2+/calmodulin-dependent protein kinase II (CaMKII), a key synaptic kinase, regulates synaptic plasticity and hippocampal memory function through N-methyl-D-aspartate re...

Fan Liu, Chen Chen, Yu-Bing Zeng et al. · 0 citations
Nov 2026

Hippocampal HMGB1/TLR4 activation elevates KYNA levels and contributes to novel-object recognition dysfunction in LPS-treated mice.

BACKGROUND Neuroinflammation is a major contributor to cognitive dysfunction, yet the mechanisms linking inflammatory signaling to synaptic dysfunction remain incompletely understood. Kynurenic acid (KYNA), an endogenous metabolite derived from tryptophan catabolism, modulates neuronal and synaptic activity, yet its in...

Ting Liu, Si-Yi Han, Xiao-Yu Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.